Regulatory T-Cell Generation and Kidney Allograft Tolerance Induced by Mesenchymal Stem Cells Associated With Indoleamine 2,3-Dioxygenase Expression

被引:280
|
作者
Ge, Wei
Jiang, Jifu
Arp, Jacqueline
Liu, Weihua [2 ]
Garcia, Bertha [2 ]
Wang, Hao [1 ,2 ,3 ]
机构
[1] Univ Western Ontario, Univ Hosp, London Hlth Sci Ctr, Multiorgan Transplant Program,Dept Surg, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada
[3] London Hlth Sci Ctr, Lawson Hlth Res Inst, London, ON, Canada
基金
加拿大创新基金会;
关键词
Tolerance; Regulatory T cells; Mesenchymal stem cells; Kidney transplantation; Indoleamine 2,3-dioxygenase; MARROW STROMAL CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROLIFERATION IN-VITRO; VERSUS-HOST-DISEASE; BONE-MARROW; DENDRITIC CELLS; TRANSPLANT RECIPIENTS; GRAFT-SURVIVAL; INHIBIT; IMMUNOSUPPRESSION;
D O I
10.1097/TP.0b013e3181fed001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The immunoregulatory properties of mesenchymal stem cells (MSCs) have been observed in vitro and in vivo. However, the underlying mechanisms of this immunomodulation remain undefined. Recent research demonstrated that MSCs express the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), known to suppress T-cell responses. This study was designed to address whether MSCs induce kidney allograft tolerance and whether IDO contributes to the immunoregulatory functions of MSCs in vivo. Methods. MSCs (1 x 10(6), intravenously) from wild-type (WT-MSCs) or IDO knockout (IDO-/--MSCs) C57BL/6 mice were injected into BALB/c recipients 24 hr after receiving a life-supporting orthotopic C57BL/6 renal graft. Results. WT-MSC-treated recipients achieved allograft tolerance with normal histology and undetectable antidonor antibody levels. Tolerant recipients demonstrated increased circulating kynurenine levels and significantly high frequencies of tolerogenic dendritic cells. They also exhibited significantly impaired CD4(+) T-cell responses consisting of decreased donor-specific proliferative ability and a Th2-dominant cytokine shift. In addition, high frequencies of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) were found in recipient spleens and donor grafts, with antibody-induced CD25(+) cell depletion confirming the critical role of Tregs in the MSC-induced tolerance. Interestingly, renal allograft recipients treated with WT MSCs concomitant with the IDO inhibitor 1-methyl-tryptophan, or those treated with IDO-/--MSCs alone, were unable to achieve allograft tolerance-revealing that functional IDO was necessary for the immunosuppression observed with WT-MSC treatment. Conclusions. IDO secreted by MSCs was responsible, at least in part, for induction of kidney allograft tolerance through generation of Tregs. This study supports the clinical application of MSCs in transplantation.
引用
收藏
页码:1312 / 1320
页数:9
相关论文
共 50 条
  • [21] Indoleamine 2,3-dioxygenase Expression in Renal Cell Carcinoma
    Scholnicoff, Ellen T.
    Wesa, Amy
    Storkus, Walter J.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 967 - 967
  • [22] Immunomodulation by dental pulp mesenchymal stem cells (SHED) is mediated by Indoleamine 2,3-dioxygenase
    Laing, A. G.
    Lombardi, G.
    Sharpe, P. T.
    IMMUNOLOGY, 2011, 135 : 207 - 207
  • [23] Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase
    Wee, Janet Lye-Keng
    Christiansen, Dale
    Li, Yu-Qin
    Boyle, William
    Sandrin, Mauro S.
    IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (05): : 460 - 465
  • [24] Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance
    Lin, Yu-Chun
    Chen, Chao-Long
    Nakano, Toshiaki
    Goto, Shigeru
    Kao, Ying-Hsien
    Hsu, Li-Wen
    Lai, Chia-Yun
    Jawan, Bruno
    Cheng, Yu-Fan
    Tateno, Chise
    Yoshizato, Katsutoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (07) : E243 - E250
  • [25] Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase
    Funeshima, N
    Fujino, M
    Kitazawa, Y
    Hara, Y
    Hara, Y
    Hayakawa, K
    Okuyama, T
    Kimura, H
    Li, XK
    JOURNAL OF GENE MEDICINE, 2005, 7 (05): : 565 - 575
  • [26] Indoleamine 2,3-dioxygenase activity is associated with regulatory T cell response in acute Puumala hantavirus infection
    Koivula, Tuisku-Tuulia
    Tuulasvaara, Anni
    Hetemaki, Iivo
    Hurme, Mikko
    Makela, Satu
    Mustonen, Jukka
    Vaheri, Antti
    Arstila, T. Petteri
    PATHOGENS AND DISEASE, 2017, 75 (01):
  • [27] Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3-dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance
    Trabanelli, S.
    Ocadlikova, D.
    Evangelisti, C.
    Parisi, S.
    Curti, A.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (15) : 2234 - 2239
  • [28] Decreased Expression of Indoleamine 2,3-Dioxygenase 1 in Dendritic Cells From Patients with Immune Thrombocytopenia Induces Impaired Regulatory T-Cell Development
    Catani, Lucia
    Sollazzo, Dana
    Trabanelli, Sara
    Evangelisti, Cecilia
    Curti, Antonio
    Polverelli, Nicola
    Palandri, Francesca
    Baccarani, Michele
    Vianelli, Nicola
    Lemoli, Roberto M.
    BLOOD, 2011, 118 (21) : 318 - 318
  • [29] Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses
    Yu, Guang
    Dai, Hong
    Chen, Jie
    Duan, Lihua
    Gong, Min
    Liu, Li
    Xiong, Ping
    Wang, Cong-Yi
    Fang, Min
    Gong, Feih
    JOURNAL OF GENE MEDICINE, 2008, 10 (07): : 754 - 761
  • [30] Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation
    Juergens, Birgit
    Raberger, Julia
    Fuchs, Dietmar
    Heitger, Andreas
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2010, 3 : 77 - 90